All Type of News
15 domestic pharmaceutical companies which have challenged to the use patent of Crestor received the ‘declaration of inadmissibility’
Domestic pharmaceutical companies which have challenged to the use patent of ‘Crestor’ received the declaration of inadmissibility.
When it comes to the nullity suit filed by 15 domestic pharmaceutical companies agai...
The Korea Pharmaceutical Manufacturers Association states “Pharmaceutical companies have triggered disorders in the distribution industry”
When it comes to the KPMA’s (Korea Pharmaceutical Manufacturers Association) current condition inspection towards distribution-disordering wholesalers, the Korea Pharmaceutical Distribution Association (KPDA) has made...
Pfizer won the ‘Prevenar’ patent nullity suit against SK ChemicalsPfizer won the Prevenar 13 patent suit proposed by SK Chemicals in 2013.
According to industry concerned on the 12th, the Intellectual Property Tribunal took the side of Pfizer...
|
‘Swift actions’ to support and compensate medical personnel and institutions for MERS-related damages
A supporting measure has been suddenly raised for medical personnel and institutions putting the best effort to prevent the spread of MERS.
The opposing parties of the government held a gathering on the 7th to regula...
Will the domestic CRO industry be collapsed?
As DreamCIS, one of the major domestic CRO companies, is purchased by a Chinese company, the people concerned has raised a worry about collapse of its industry.
Although the government mentioned about an active measu...
Boryung Pharmaceutical is about to expand to the Asian market with ‘Kanarb’It is known that the Boryung Pharmaceutical’s self-developed new hypertension treatment, ‘Kanarb,’ will soon be advanced to the Asian market.
According to the industry concerne...
|
The pharmaceutical association will get on inspection of distribution companies causing irregularities
The Korea Pharmaceutical Manufacturers Association (KPMA) decided to review a measure to inspect the actual condition of pharmaceutical distribution companies disturbing the pharmaceutical distribution order. In order...
So-called ‘MERS clinics’ worry about “staff salaries and re-openings”
As of the 10th, the number of hospitals occurred or passed through by MERS patients was increased to 44 in the total 7 cities.
According to damage cases collected by the MERS Response Center of the Korean Medical Ass...
‘Five reasons’ why the Foreign Patents Attraction Act must pass immediately
The government has put on drive with the National Assembly process for the Foreign Patients Attraction Act on June. As the opposing parties have shown positive opinions, it seems to overcome a part of negative public ...
BMS CEO will be replaced while CEO Eun-young Kim is appointed as the new CEO of Allergan Korea
It has been 9 months. BMS Korea CEO is changed again.
According to the industry concerned on the 11th, CEO Eun-young Kim of its Korean branch left the company. It has been approximately 9 months since the appointment...
